EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

A two-center registry of high-risk percutaneous coronary intervention with Impella CP support: the KRAKpella Registry — age and vasoactive agents use as independent in-hospital mortality risk factors

Stanisław Bartuś, Artur Pawlik, Artur Dziewierz, Łukasz Rzeszutko, Łukasz Niewiara, Jan Roczniak, Ewa Kwiatkowska, Karol Kasprzycki, Bernadeta Chyrchel, Michał Chyrchel, Grzegorz Heba, Wojciech Zasada und 16 weitere

Polish Heart Journal · 2025

DOI: 10.33963/v.phj.106801 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Polish Heart Journal, 2025. Verfasst von Stanisław Bartuś und 27 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Heart-Assist Devices, Hospital Mortality, Coronary Artery Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High-risk percutaneous coronary intervention (PCI) in patients with complex coronary artery disease (CAD), multiple comorbidities, and reduced left ventricular ejection fraction (LVEF) carries significant risk of hemodynamic compromise. Percutaneous left ventricular assist devices (Impella CP, Abiomed, Danvers, MA, US) may provide beneficial left ventricular support during these procedures. This study aimed to identify factors influencing outcomes of patients deemed unsuitable for bypass surgery who underwent high-risk PCI with Impella CP support.Material and methods: This two-center observational study enrolled non-shock patients undergoing elective and semi-elective high-risk PCI with Impella CP support between June 2017 and January 2024. The analysis included patient demographics, comorbidities, procedural characteristics, and clinical outcomes.

Results

The study population comprised 171 patients (86.5% male) with substantial comorbidities: diabetes mellitus (50.3%), chronic kidney disease (43.9%), nicotine addiction (26.3%), and peripheral artery disease (22.8%). Median LVEF was 22.0% (IQR 18.0–26.0). Most patients had extensive CAD, with multivessel involvement in 90.7% and left main CAD in 66.1%. In-hospital mortality was 5.8%, and 1-year all-cause mortality reached 14.6%. Advanced age and periprocedural vasoactive agent requirement emerged as independent predictors of in-hospital mortality.

Conclusions

This registry demonstrates that Impella CP-supported high-risk PCI is feasible and relatively safe in patients with complex CAD and severely reduced LVEF. Advanced age and requirement for periprocedural vasopressors emerged as significant predictors of in-hospital mortality. Further studies are needed to identify patients most likely to benefit from this intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionHeart-Assist DevicesHospital MortalityCoronary Artery DiseaseHumansMaleFemaleAgedMiddle AgedRegistriesRisk FactorsAge Factors

Stichwörter der Autor:innen

PCIheart failurepLVADrevascularization

Autor:innen und Institutionen

  • Clinical Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland.
  • 2nd Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
  • Clinical Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland. arturo.pawlik@gmail.com.
  • Clinical Department of Interventional Cardiology, St. John Paul II Hospital, Kraków, Poland.
  • Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
  • Students' Scientific Group of Modern Cardiac Therapy at the Department of Interventional Cardiology, Jagiellonian University Medical College, St. John Paul II Hospital, Kraków, Poland.

Zitieren

APA

Bartuś, S., Pawlik, A., Dziewierz, A., Rzeszutko, Ł., Niewiara, Ł., Roczniak, J., Kwiatkowska, E., Kasprzycki, K., Chyrchel, B., Chyrchel, M., Heba, G., Zasada, W., Cugowska, M., Gruszka, K., Sabatowski, K., Suska, M., Klima, Ł., Terlecki, M., Szolc, P., …, & Legutko, J. (2025). A two-center registry of high-risk percutaneous coronary intervention with Impella CP support: the KRAKpella Registry — age and vasoactive agents use as independent in-hospital mortality risk factors. Polish Heart Journal. https://doi.org/10.33963/v.phj.106801

Vancouver

Bartuś S, Pawlik A, Dziewierz A, Rzeszutko Ł, Niewiara Ł, Roczniak J, et al. A two-center registry of high-risk percutaneous coronary intervention with Impella CP support: the KRAKpella Registry — age and vasoactive agents use as independent in-hospital mortality risk factors. Polish Heart Journal. 2025. doi:10.33963/v.phj.106801

BibTeX
@article{Bartu2025,
  author = {Bartuś, Stanisław and Pawlik, Artur and Dziewierz, Artur and Rzeszutko, Łukasz and Niewiara, Łukasz and Roczniak, Jan and Kwiatkowska, Ewa and Kasprzycki, Karol and Chyrchel, Bernadeta and Chyrchel, Michał and Heba, Grzegorz and Zasada, Wojciech and Cugowska, Monika and Gruszka, Krystian and Sabatowski, Karol and Suska, Marcin and Klima, Łukasz and Terlecki, Michał and Szolc, Piotr and Rakowski, Tomasz and Wojdyła, Roman and Sorysz, Danuta and Wizimirski, Marcin and Rajzer, Marek and Surdacki, Andrzej and Bryniarski, Leszek and Kleczyński, Paweł and Legutko, Jacek},
  title = {A two-center registry of high-risk percutaneous coronary intervention with Impella CP support: the KRAKpella Registry — age and vasoactive agents use as independent in-hospital mortality risk factors},
  journal = {Polish Heart Journal},
  year = {2025},
  doi = {10.33963/v.phj.106801}
}
Kostenlos starten →